Daniel D. De Carvalho

13.5k total citations · 6 hit papers
60 papers, 6.1k citations indexed

About

Daniel D. De Carvalho is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Daniel D. De Carvalho has authored 60 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 16 papers in Immunology and 15 papers in Cancer Research. Recurrent topics in Daniel D. De Carvalho's work include Epigenetics and DNA Methylation (30 papers), Cancer Genomics and Diagnostics (10 papers) and RNA modifications and cancer (10 papers). Daniel D. De Carvalho is often cited by papers focused on Epigenetics and DNA Methylation (30 papers), Cancer Genomics and Diagnostics (10 papers) and RNA modifications and cancer (10 papers). Daniel D. De Carvalho collaborates with scholars based in Canada, United States and Brazil. Daniel D. De Carvalho's co-authors include Peter A. Jones, Gangning Liang, Ankur Chakravarthy, Theresa K. Kelly, Han Han, Xiaojing Yang, Fides D. Lay, Shu Yi Shen, Helen Loo Yau and Jueng Soo You and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Daniel D. De Carvalho

54 papers receiving 6.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts

2015 987 citations Helen Loo Yau, Rajat Singhania et al. Cell profile →
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer

2014 853 citations Xiaojing Yang, Han Han et al. Cancer Cell profile →
Epigenetic modifications as therapeutic targets

2010 593 citations Daniel D. De Carvalho, Peter A. Jones et al. profile →
TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure

2018 474 citations Ankur Chakravarthy, Daniel D. De Carvalho et al. profile →
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade

2018 462 citations Wanqiang Sheng, Martin W. LaFleur et al. Cell profile →
Epigenetic therapy in immune-oncology

2019 368 citations Peter A. Jones, Ankur Chakravarthy et al. profile →

Peers

Countries citing papers authored by Daniel D. De Carvalho

Since Specialization

Citations

This map shows the geographic impact of Daniel D. De Carvalho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel D. De Carvalho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel D. De Carvalho more than expected).

Fields of papers citing papers by Daniel D. De Carvalho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel D. De Carvalho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel D. De Carvalho. The network helps show where Daniel D. De Carvalho may publish in the future.

Co-authorship network of co-authors of Daniel D. De Carvalho

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel D. De Carvalho. A scholar is included among the top collaborators of Daniel D. De Carvalho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel D. De Carvalho. Daniel D. De Carvalho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype 2024 ·Acta Neuropathologica ·Farshad Nassiri, (unknown), Vikas Patil, Yasin Mamatjan, Jeff Liu, Justin Z. Wang, Mathew Voisin, Romina Nejad, Sheila Mansouri, Shirin Karimi, Ankur Chakravarthy, Eric X. Chen, Daniel D. De Carvalho, Kenneth Aldape, Gelareh Zadeh	0
2	Modeling methyl-sensitive transcription factor motifs with an expanded epigenetic alphabet 2024 ·Genome biology ·Coby Viner, Charles A. Ishak, James Johnson, Nicolas J. Walker, Hui Shi, Marcela Sjöberg, Shu Yi Shen, (unknown), David J. Adams, Anne C. Ferguson‐Smith, Daniel D. De Carvalho, Sarah J. Hainer, Timothy L. Bailey, Michael M. Hoffman	8
3	The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell population 2023 ·Frontiers in Immunology ·Tiago da Silva Medina, Alex Murison, Michelle I. Smith, Gabriela Sarti Kinker, Ankur Chakravarthy, Glauco Akelinghton Freire Vitiello, Williams Turpin, Shu Yi Shen, Helen Loo Yau, Olga F. Sarmento, William A. Faubion, Mathieu Lupien, Mark S. Silverberg, C.H. Arrowsmith, Daniel D. De Carvalho	7
4	METABOLOGENOMIC CHARACTERIZATION UNCOVERS HETEROGENEITY AMONG IDH MUTANT GLIOMAS 2023 ·Neuro-Oncology Advances ·(unknown), Farshad Nassiri, Justin Z. Wang, Yasin Mamatjan, Romina Nejad, Vikas Patil, Jeff Liu, Mathew Voisin, Sheila Mansouri, Shirin Karimi, Ankur Chakravarthy, Eric X. Chen, Daniel D. De Carvalho, Kenneth Aldape, Gelareh Zadeh	0
5	Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia 2023 ·British Journal of Haematology ·Fabíola Attié de Castro, Parinaz Mehdipour, Ankur Chakravarthy, Ilias Ettayebi, Helen Loo Yau, Tiago da Silva Medina, Sajid A. Marhon, (unknown), (unknown), Andrea Arruda, Rebecca Devlin, Lorena Lôbo de Figueiredo-Pontes, Fernando Chahud, Maira da Costa Cacemiro, Mark D. Minden, Vikas Gupta, Daniel D. De Carvalho	2
6	Sensitive and reproducible cell-free methylome quantification with synthetic spike-in controls 2022 ·Cell Reports Methods ·Samantha L. Wilson, Shu Yi Shen, (unknown), Justin Burgener, Timothy J. Triche, Scott V. Bratman, Daniel D. De Carvalho, Michael M. Hoffman	4
7	Building the Canadian Bladder Cancer Research Network (CBCRN): Progress During a Pandemic 2022 ·Canadian Urological Association Journal ·Peter C. Black, Nimira Alimohamed, Wassim Kassouf, John L. Gore, Kathy D. McCoy, Brad H. Nelson, Daniel D. De Carvalho, Rodney J. Ouellette, (unknown), (unknown), D. Robert Siemens, David M. Berman, Srikala S. Sridhar, Girish S. Kulkarni	1
8	Endogenous retroelements as alarms for disruptions to cellular homeostasis 2022 ·Trends in cancer ·(unknown), Raymond Chen, Daniel D. De Carvalho	14
9	Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma 2021 ·Clinical Cancer Research ·Justin Burgener, Jinfeng Zou, Zhen Zhao, (unknown), Shu Yi Shen, Shao Hui Huang, Sareh Keshavarzi, Wei Xu, Fei‐Fei Liu, Geoffrey Liu, John Waldron, Ilan Weinreb, Anna Spreafico, Lillian L. Siu, John R. de Almeida, David P. Goldstein, Michael M. Hoffman, Daniel D. De Carvalho, Scott V. Bratman	53
10	Clinical advances in targeting epigenetics for cancer therapy 2021 ·FEBS Journal ·Shengrui Feng, Daniel D. De Carvalho	65
11	Measuring the effect of drug treatments on primary human CD8+ T cell activation and cytolytic potential 2021 ·STAR Protocols ·Helen Loo Yau, Daniel D. De Carvalho	1
12	Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency 2020 ·Nature ·Parinaz Mehdipour, Sajid A. Marhon, Ilias Ettayebi, Ankur Chakravarthy, Amir Hosseini, Yadong Wang, Fabíola Attié de Castro, Helen Loo Yau, Charles A. Ishak, Sagi Abelson, Catherine O′Brien, Daniel D. De Carvalho	166
13	Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA 2019 ·Nature Protocols ·Shu Yi Shen, Justin Burgener, Scott V. Bratman, Daniel D. De Carvalho	113
14	LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade breakdown → 2018 ·Cell ·Wanqiang Sheng, Martin W. LaFleur, Thao H. Nguyen, Sujun Chen, Ankur Chakravarthy, Jake R. Conway, Ying Li, Hao Chen, Henry Yang, Pang‐Hung Hsu, Eliezer M. Van Allen, Gordon J. Freeman, Daniel D. De Carvalho, Housheng Hansen He, Arlene H. Sharpe, Yang Shi	462
15	IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils Recruitment 2015 ·Cancer Research ·Luciana Benevides, Denise Morais da Fonseca, Paula B. Donate, Daniel Guimarães Tiezzi, Daniel D. De Carvalho, Jurandyr Moreira de Andrade, Gislâine A. Martins, João S. Silva	136
16	Symmetrical Dose-Dependent DNA-Methylation Profiles in Children with Deletion or Duplication of 7q11.23 2015 ·The American Journal of Human Genetics ·(unknown), Darci T. Butcher, Rajat Singhania, Carolyn Β. Mervis, Colleen A. Morris, Daniel D. De Carvalho, Rosanna Weksberg, Lucy R. Osborne	49
17	Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer breakdown → 2014 ·Cancer Cell ·Xiaojing Yang, Han Han, Daniel D. De Carvalho, Fides D. Lay, Peter A. Jones, Gangning Liang	853
18	Constitutive Androstane Receptor Ligands Modulate the Anti-Tumor Efficacy of Paclitaxel in Non-Small Cell Lung Cancer Cells 2014 ·PLoS ONE ·Heidge Fukumasu, Arina Lázaro Rochetti, Pedro Ratto Lisboa Pires, Edson Roberto da Silva, Lígia Garcia Mesquita, Ricardo de Francisco Strefezzi, Daniel D. De Carvalho, M.L. Dagli	13
19	Nucleosomes Containing Methylated DNA Stabilize DNA Methyltransferases 3A/3B and Ensure Faithful Epigenetic Inheritance 2011 ·PLoS Genetics ·Shikhar Sharma, Daniel D. De Carvalho, Shinwu Jeong, Peter A. Jones, Gangning Liang	91
20	BCR–ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients 2010 ·Oncogene ·Daniel D. De Carvalho, Renata Binato, Welbert Oliveira Pereira, (unknown), (unknown), Rodrigo Proto‐Siqueira, (unknown), Marco A. Zago, Maria Aparecida Zanichelli, Eliana Abdelhay, Fabíola Attié de Castro, Jacqueline F. Jacysyn, Gustavo P. Amarante‐Mendes	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact